Ophthalmic Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2018

Transparency Market Research Reports included a detailed market survey and analysis trends on Ophthalmic Drugs Market. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure.

The global ophthalmic drugs market is rapidly growing due to increasing prevalence of eye disorders such as glaucoma, dry eye diseases and retinal diseases. Changing lifestyle, improved medical infrastructure, technological changes, increase in healthcare spending and aging population is also supporting the growth of the ophthalmic drugs market.

Browse Full Report:- http://www.transparencymarketresearch.com/ophthalmic-drugs-market.html

Glaucoma is the largest drugs segment in global ophthalmic drugs market. Some of the major drugs for glaucoma treatment are Lumigan, Combigan, Xalatan, Ganfort and Saflutan. Diquas, Hyalein and Restasis are the major drugs for dry eye diseases. The retinal drugs market includes Ozurdex, Macugen, Visudyne and Lucentis. Patanol/Pataday, Tobradex, Vigamox and Bepreve are major ocular anti-inflammatory drugs. The ophthalmic drugs market covers prescription based drugs, OTC drugs and pipeline drugs. This report forecasts future potential of all these drug markets and analyses drivers and opportunities, restraints and challenges, market trends, Porter’s forces, competitive landscape and company profiles of key players.

The report categorizes the global ophthalmic drugs market based on major eye disorders, treatment drugs and geography. The treatment drugs market comprises treatment of major eye disorders such as glaucoma, dry eye drugs, retinal diseases and ocular inflammatory diseases. The market is further segmented on the basis of prescription based drugs, OTC drugs and pipeline drugs in different eye disorder areas. In the segment of geographic analysis, the report identifies and analyses market sizes and forecast of North America, Europe, Asia Pacific and Rest of the World (RoW). North America region covers the scenario of the US. Europe region covers the scenario of France, Germany and the UK. Asia Pacific region highlights the scenario of India, China and Japan.

Table of Content
Chapter 1 Preface 8
Chapter 2 Executive Summary 10
Chapter 3 Ophthalmic Drugs – Industry Analysis 11
Chapter 4 Ophthalmic Drugs Market Trends 18
Chapter 5 Porter’s Five Force Analysis 20
Chapter 6 Global Market Size and Forecast 22
Chapter 7 Ophthalmic Drugs Market – Treatment Drugs 25
Chapter 8 Ophthalmic Drugs Market: Regional Analysis 34
Chapter 9 Prescription vs. Over the Counter Drugs 55
Chapter 10 Competitive Landscape 57
Chapter 11 Company Profiles 62

List of Figures

FIG. 1 Profiles of aging population in major countries (%, 2000-2050) 13
FIG. 2 Global ophthalmic drugs market: Porter’s five force analysis 20
FIG. 3 Key players market share in the global ophthalmic drugs market in 2012 57
FIG. 4 Ophthalmic drugs market strategic developments (2011-2013) 58

List of Tables

TABLE 1 Drivers for ophthalmic drugs market: Impact analysis 11
TABLE 2 Global data on visual impairment, by region (million, 2002 and 2010) 12
TABLE 3 Restraints for ophthalmic drugs market: Impact analysis 15
TABLE 4 Out of pocket expenditure of developing and developed countries 17
TABLE 5 Major combination therapy drugs worldwide 18
TABLE 6 Major merger and acquisitions in the ophthalmic drug market 19
TABLE 7 Global Ophthalmic drugs market size, by geography 2008-2012 (USD million) 22
TABLE 8 Global Ophthalmic drugs market size, by geography 2013-2018(USD millions) 23
TABLE 9 Global Ophthalmic drugs market size, by disease 2008-2012 (USD million) 23
TABLE 10 Global Ophthalmic drugs market size, by disease 2013-2018 (USD million) 24
TABLE 11 Dry eye drugs market 2010-2012 (USD million) 25
TABLE 12 Dry eye drugs market 2013-2018 (USD million) 26
TABLE 13 Major dry eye drugs pipeline 26
TABLE 14 Retinal drugs market 2010-2012 (USD million) 27
TABLE 15 Retinal drugs market 2013-2018 (USD million) 28
TABLE 16 Major retinal disease drugs pipeline 28
TABLE 17 Anti-allergy/inflammatory drugs market 2010-2012 (USD million) 29
TABLE 18 Anti-allergy/inflammatory drugs market 2013-2018 (USD million) 30
TABLE 19 Major anti-inflammatory/allergy/anti-infective drugs pipeline 30
TABLE 20 Prevalence of glaucoma, by geographic regions (million, 2010-2020) 31
TABLE 21 Major anti-glaucoma drugs market 2010-2012 (USD million) 32
TABLE 22 Major anti-glaucoma drugs market 2013-2018 (USD million) 32
TABLE 23 Anti-glaucoma drugs pipeline 33
TABLE 24 North America Ophthalmic drugs market size, by geography 2008-2012 (USD million) 34
TABLE 25 North America Ophthalmic drugs market size, by geography 2013-2018 (USD million) 35
TABLE 26 North America Ophthalmic drugs market size, by disease 2008-2012 (USD million) 35
TABLE 27 North America ophthalmic drugs market, by disease 2013-2018 (USD million) 36
TABLE 28 Ophthalmic drugs market, by disease in US 2008-2012(USD million) 37
TABLE 29 Ophthalmic drugs market by disease in US 2013-2018 (USD million) 37
TABLE 30 European Ophthalmic drugs market size, by geography 2008-2012 (USD million) 38
TABLE 31 European Ophthalmic drugs market size, by geography 2013-2018 (USD million) 39
TABLE 32 European ophthalmic drugs market by disease 2008-2012 (USD million) 40
TABLE 33 European ophthalmic drugs market by disease 2013-2018 (USD million) 40
TABLE 34 French ophthalmic drugs market by disease 2008-2012 (USD million) 41
TABLE 35 French ophthalmic drugs market, by disease 2013-2018 (USD million) 42
TABLE 36 German Ophthalmic drugs market, by disease 2008-2012 (USD million) 43
TABLE 37 German ophthalmic drugs market, by disease 2013-2018 (USD million) 43
TABLE 38 The UK ophthalmic drugs market, by disease 2008-2012 (USD million) 45
TABLE 39 The UK ophthalmic drugs market, by disease 2013-2018 (USD million) 45
TABLE 40 Asian Ophthalmic drugs market size, by country 2008-2012 (USD million) 46
TABLE 41 Asian Ophthalmic drugs market size, by geography 2013-2018 (USD million) 47
TABLE 42 Asian ophthalmic drugs market, by disease 2008-2012 (USD million) 47
TABLE 43 Asian ophthalmic drugs market, by disease 2013-2018 (USD million) 48
TABLE 44 Indian ophthalmic drugs market, by disease 2008-2012 (USD million) 49
TABLE 45 Indian ophthalmic drugs market, by disease 2013-2018 (USD million) 50
TABLE 46 Chinese ophthalmic drugs market, by disease 2008-2012 (USD million) 51
TABLE 47 Chinese ophthalmic drugs market, by disease 2013-2018 (USD million) 52
TABLE 48 Japanese ophthalmic drugs market, by disease 2008-2012 (USD million) 53
TABLE 49 Japanese ophthalmic drugs market, by disease 2013-2018 (USD million) 53
TABLE 50 Ophthalmic drugs market, by prescription vs. over the counter drugs 2008-2012 (USD million) 55
TABLE 51 Ophthalmic drugs market, by prescription vs. over the counter drugs 2013-2018 (USD million) 56
TABLE 52 Major product launches in ophthalmic drugs market (2011-2013) 59
TABLE 53 R&D initiatives in ophthalmic drugs market (2012-2013) 60
TABLE 54 Mergers and acquisitions in ophthalmic drugs market (2011-2013) 61

More Reports On Pharmaceutical Market: – http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us:-
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:-
http://www.tmrblog.com/
http://mrreports.wordpress.com/
http://marketsandresearch.blogspot.com/

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s